Top

Published in:

Open Access 01-12-2021 | Diarrhea | Research article

Time series analysis of the relationship between diarrhea in children and Rota 2 vaccine in the Fanteakwa District of the eastern region of Ghana

Authors: James Atampiiga Avoka, Elvis J. Dun-Dery, Issah Seidu, Armel N. E. Abou, Paul Twene, Isaac Obeng Tandoh, Frederick Dun-Dery

Published in: BMC Pediatrics | Issue 1/2021

Abstract

Background

Rotavirus is considered the main causal factor of severe gastroenteritis among infants and children globally. The association with severe rotavirus infection is mostly worse among the least developed countries, mainly due to inadequate access to medical care and poverty. This study was conducted to determine the seasonal effects in respect of diarrhea cases in children, the association between diarrhea cases and Rota2 vaccine in the Fanteakwa District of the Eastern Region of Ghana.

Methods

The study compares monthly diarrhea cases against children vaccinated with Rota2 extracted from DHIMS2 spanning May 2012 to December 2017 in Fanteakwa District. A univariate association between diarrhea cases and children vaccinated with Rota 2 was conducted using the R-software version 3.4.4 with the use of forecast, tseries and TSAPred. Pearson Correlation coefficient was also computed between monthly diarrhea cases and Rota 2 as well as lagged values of Rota 2 and Diarrhea cases.

Results

The study shows that February recorded the highest average number of diarrhea cases (172) over the period 2012 to 2017 with a standard deviation of 59. However, a one-way analysis of variance shows a significant difference amongst the monthly averages with an F-statistic of 0.042 and P-value of 0.064. It is observed that the correlations between each of the Rota2 doses and the lagged cases are positive, showing higher Rota2 doses a month ago ((X_t − 1),0.346 to 0.735), two months ago ((X_t − 2),0.383 to 0.746), three months ago ((X_t − 3), 0.330 to 0.737) and four months ago ((X_t − 4), 0.236 to 0.723) are associated with lower diarrhea cases. The results also show that an increase in the previous two month’s Rota2 figures by 100 is associated with a significant decrease in the currently expected diarrhea cases by approximately 36.

Conclusion

Seasonal variations exist in the occurrence of diarrhea in children, with January recording the highest number of diarrhea cases (172). There is a relationship between episodes of diarrhea in children and Rota2 (p-value = 0.064); thus, the more children are vaccinated with Rota2, the less diarrhea cases are recorded. Diarrhea cases in Fanteakwa district are generally low, except 2013 and 2016 where the cases are higher than the rest of the other years.

Anwari P, Debellut F, Pecenka C, Parwiz SM, Clark A, Groman D, et al. Potential impact and cost-effectiveness of rotavirus vaccination in Afghanistan. Vaccine. 2018;36(51):7769–74. https://doi.org/10.1016/j.vaccine.2017.10.058.CrossRefPubMedPubMedCentral

Atinga RA, Kuganab-lem RB, Aziato L, Srofenyoh E. Strengthening quality of acute care through feedback from patients in Ghana. African J Emerg Med. 2015;5(1):24–30. https://doi.org/10.1016/j.afjem.2014.10.008.CrossRef

Banajeh SM, Abu-asba BA. The epidemiology of all-cause and rotavirus acute gastroenteritis and the characteristics of rotavirus circulating strains before and after rotavirus vaccine introduction in Yemen : analysis of hospital-based surveillance data. BMC Infect Dis. 2015;15(418):1–10. https://doi.org/10.1186/s12879-015-1165-8.CrossRef

Bucardo F, Mercado J, Reyes Y, González F, Balmaseda A, Nordgren J. Large increase of rotavirus diarrhoea in the hospital setting associated with emergence of G12 genotype in a highly vaccinated population in Nicaragua. Clin Microbiol Infect. 2015;21(6):603.e1–7. https://doi.org/10.1016/j.cmi.2015.01.022.CrossRef

Coldiron ME, Guindo O, Makarimi R, Soumana I, Matar A, Garba S, et al. Safety of a heat-stable rotavirus vaccine among children in Niger : data from a phase 3 , randomized , double-blind , placebo-controlled trial. Vaccine. 2018;36(25):3674–80. https://doi.org/10.1016/j.vaccine.2018.05.023.CrossRefPubMed

Cortes J, Curns AT, Tate JE, Cortese MM, Patel MM, Zhou F, Parashar UD. Rotavirus vaccine and health care utilization for diarrhea in U.S. children. New England J Med. 2011;17(365:1108):10.

Cortese MM, Dahl RM, Curns AT. Protection against gastroenteritis in US households with children who received rotavirus vaccine. J Infect Dis. 2015:211. https://doi.org/10.1093/infdis/jiu503.

Desselberger U, Gray J. Differences of rotavirus vaccine effectiveness by country : likely causes and contributing factors. Pathogens. 2017;(figure 1):1–13. https://doi.org/10.3390/pathogens6040065.

Dhital S, Sherchand JB, Pokhrel BM, Parajuli K, Shah N. Molecular epidemiology of rotavirus causing diarrhea among children less than five years of age visiting national level children hospitals , Nepal. BMC Pediatr. 2017;17(101):1–7. https://doi.org/10.1186/s12887-017-0858-0.CrossRef

10.

Enweronu-laryea CC, Sagoe KW, Damanka S, Lartey B, Armah GE. Rotavirus genotypes associated with childhood severe acute diarrhoea in southern Ghana: a cross-sectional study. Virol J. 2013;10(287):1–6.

11.

Glass RI, Parashar UD, Bresee JS, Turcios R, Fischer TK, Widdowson MA, et al. Rotavirus vaccines: current prospects and future challenges. Lancet. 2006;368(9532):323–32. https://doi.org/10.1016/S0140-6736(06)68815-6.CrossRefPubMed

12.

Harris VC, Armah G, Fuentes S, Korpela KE, Parashar U, Victor JC, et al. Signi fi cant correlation between the infant gut microbiome and rotavirus vaccine response in rural Ghana; 2017. p. 215. https://doi.org/10.1093/infdis/jiw518.CrossRef

13.

Kim K, Lee G, Thanh HD, Kim J, Konkit M, Yoon S, et al. Exopolysaccharide from lactobacillus plantarum LRCC5310 offers protection against rotavirus-induced diarrhea and regulates inflammatory response. J Dairy Sci. 2018;101(7):5702–12. https://doi.org/10.3168/jds.2017-14151.CrossRefPubMed

14.

Kumi-kyereme A, Amo-adjei J. Household wealth , residential status and the incidence of diarrhoea among children under-five years in Ghana. J Epidemiol Glob Health. 2016;6(3):131–40. https://doi.org/10.1016/j.jegh.2015.05.001.CrossRefPubMed

15.

Liu L, Qian Y, Zhang Y, Zhao L, Jia L, Dong H. Epidemiological aspects of rotavirus and adenovirus in hospitalized children with diarrhea : a 5-year survey in Beijing. BMC Infect Dis. 2016;16(507):1–7. https://doi.org/10.1186/s12879-016-1829-z.CrossRef

16.

Madeleine G, Yen C, Cortes J, Arau A, Lopman B, Flannery B, et al. Decline in diarrhea mortality and admissions after routine childhood rotavirus immunization in Brazil : a time-series analysis. PLoS Med. 2011;8(4):1–11. https://doi.org/10.1371/journal.pmed.1001024.CrossRef

17.

Miramont S, Fenollar F, Minodier P, Boutin A, Laporte R, Br V, et al. Tropheryma whipplei associated with diarrhoea in young children. Clin Microbiol Infect. 2016;22:869–74. https://doi.org/10.1016/j.cmi.2016.07.005.CrossRefPubMed

18.

Mohammadkhah AI, Simpson EB, Patterson SG, Ferguson JF. Development of the gut microbiome in children, and lifetime implications for obesity and Cardiometabolic disease. Children. 2018;5(12):160. https://doi.org/10.3390/children5120160.CrossRefPubMedCentral

19.

Moore RE, Townsend SD. Temporal development of the infant gut microbiome. Open Biol. 2019;9(9). https://doi.org/10.1098/rsob190128.

20.

Muendo C, Laving A, Kumar R, Osano B, Egondi T, Njuguna P. Prevalence of rotavirus infection among children with acute diarrhoea after rotavirus vaccine introduction in Kenya , a hospital cross-sectional study. BMC Pediatr. 2018;18(323):1–9.

21.

Nakawesi JS, Wobudeya E, Ndeezi G, Mworozi EA, Tumwine JK. Prevalence and factors associated with rotavirus infection among children admitted with acute diarrhea in Uganda. BMC Pediatr. 2010;10(69).

22.

Neuzil KM, Kotloff KL. Community-acquired diarrhoea in a world with rotavirus vaccine : a glimpse into the future. Lancet Glob Health. 2015;3(9):e510–1. https://doi.org/10.1016/S2214-109X(15)00052-2.CrossRefPubMed

23.

Ngabo F, Tate JE, Gatera M, Rugambwa C, Donnen P, Lepage P, et al. Effect of pentavalent rotavirus vaccine introduction on hospital admissions for diarrhoea and rotavirus in children in Rwanda : a time-series analysis. Lancet Glob Health. 2008;4(2):e129–36. https://doi.org/10.1016/S2214-109X(15)00270-3.CrossRef

24.

Ngabo F, Tate JE, Gatera M, Rugambwa C, Donnen P, Lepage P, et al. Eff ect of pentavalent rotavirus vaccine introduction on hospital admissions for diarrhoea and rotavirus in children in Rwanda : a time-series analysis. Lancet Glob Health. 2016;4(2):e129–36. https://doi.org/10.1016/S2214-109X(15)00270-3.CrossRefPubMed

25.

Nonvignon J, Atherly D, Pecenka C, Aikins M, Gazley L, Groman D, et al. Cost-effectiveness of rotavirus vaccination in Ghana : examining impacts from 2012 to 2031. Vaccine. 2018;36(47):7215–21. https://doi.org/10.1016/j.vaccine.2017.11.080.CrossRefPubMedPubMedCentral

26.

Path. Rotavirus disease and vaccines in Ghana; 2013.

27.

Santos CB, Araújo KCG, Jardim-Botelho A, Santos MB, Rodrigues A, Dolabella SS, Gurgel RQ. Diarrhea incidence and intestinal infections among rotavirus vaccinated infants from a poor area in Brazil: A spatial analysis. BMC Public Health. 2014;14(1). https://doi.org/10.1186/1471-2458-14-399.

28.

Schwartz LM, Halloran ME, Rowhani-rahbar A, Neuzil KM, Victor JC. Rotavirus vaccine effectiveness in low-income settings : an evaluation of the test-negative design. Vaccine. 2017;35(1):184–90. https://doi.org/10.1016/j.vaccine.2016.10.077.CrossRefPubMedPubMedCentral

29.

Shumetie G, Gedefaw M, Kebede A, Derso T. Exclusive breastfeeding and rotavirus vaccination are associated with decreased diarrheal morbidity among under-five children in Bahir Dar , Northwest Ethiopia. Public Health Rev. 2018;39(28):1–10.

30.

Teran CG, Teran-escalera CN, Villarroel P, Patin SI. Nitazoxanide vs. probiotics for the treatment of acute rotavirus diarrhea in children : a randomized , single-blind , controlled trial in Bolivian children. Int J Infect Dis. 2009;13:518–23. https://doi.org/10.1016/j.ijid.2008.09.014.CrossRefPubMed

31.

Tian Y, Chughtai AA, Gao Z, Yan H, Chen Y, Liu B, et al. Prevalence and genotypes of group a rotavirus among outpatient children under five years old with diarrhea in Beijing , China, 2011–2016. BMC Infect Dis. 2018;18(497):1–11.

32.

Vrdoljak M, Gu M, Trkulja V, Buti I, Ivi I, Hegedu M, et al. Distribution of rotavirus genotypes in three Croatian regions among children 5 years of age ( 2012–2014 ). Int J Infect Dis. 2019;89:3–9. https://doi.org/10.1016/j.ijid.2019.09.008.CrossRefPubMed

33.

Ward RL, Bernstein DI. Rotarix : a rotavirus vaccine for the world. Clin Infect Dis. 2009;48(August):222–8. https://doi.org/10.1086/595702.CrossRefPubMed

34.

Yen AC, Tate JE. Diarrhea-associated hospitalizations among US children over 2 rotavirus seasons after vaccine introduction. 2019;127(1). https://doi.org/10.1542/peds.2010-1393.

35.

Gujarati DN. Essentials of Econometrics 4th Edition. McGraw-Hill Publications; 2009. ISBN: 9780073375847.

36.

Hyndman RJ, Khandakar Y. Automatic time series forecasting: the forecast package for R. J Stat Software. 2008;27(3):22. Retrieved from http://www.jstatsoft.org/v27/i03/paper.

37.

Armah GE, Sow SO, Breiman RF, Dallas MJ, Tapia MD, Feikin DR, Neuzil KM. Efficacy of pentavalent rotavirus vaccine against severe rotavirus gastroenteritis in infants in developing countries in sub-Saharan Africa: a randomised, double-blind, placebo-controlled trial. Lancet. 2010;376(9741):606–14. https://doi.org/10.1016/S0140-6736(10)60889-6.

38.

CDC. Update_ Measles --- United States, January--July 2008. 2008.

39.

Ichihara MYT, Rodrigues LC, Teles Santos CAS, Teixeira M, da GLC, De Jesus SR, Alvim De Matos SM, Barreto ML. Effectiveness of rotavirus vaccine against hospitalized rotavirus diarrhea: A case-control study. Vaccine. 2014;32(23):2740–7. https://doi.org/10.1016/j.vaccine.2014.01.007.

40.

World Health Organization. Vaccine-preventable diseases and immunization programme: programme report and future initiatives 2001-2005. 2005.

41.

Hanlon P, et al. Trial of an attenuated bovine rotavirus vaccine (RIT 4237) in Gambian infants. Lancet. 1987;1:1342-5.

Title: Time series analysis of the relationship between diarrhea in children and Rota 2 vaccine in the Fanteakwa District of the eastern region of Ghana
Authors: James Atampiiga Avoka
Elvis J. Dun-Dery
Issah Seidu
Armel N. E. Abou
Paul Twene
Isaac Obeng Tandoh
Frederick Dun-Dery
Publication date: 01-12-2021
Publisher: BioMed Central
Keywords: Diarrhea
Diarrhea
Published in: BMC Pediatrics / Issue 1/2021
Electronic ISSN: 1471-2431
DOI: https://doi.org/10.1186/s12887-021-02540-3

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Time series analysis of the relationship between diarrhea in children and Rota 2 vaccine in the Fanteakwa District of the eastern region of Ghana

Abstract

Background

Methods

Results

Conclusion

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Background

Methods

Results

Conclusion

Please log in to get access to this content

Other articles of this Issue 1/2021

Sociodemographic characteristics are associated with prevalence of high-risk waist circumference and high-risk waist-to-height ratio in U.S. adolescents

The effect of care provided by paediatric critical care transport teams on mortality of children transported to paediatric intensive care units in England and Wales: a retrospective cohort study

A rare case of fetus in fetu in the sacrococcygeal region: CT and MRI findings

Thymus size and its correlates among children admitted with severe acute malnutrition: a cross-sectional study in Uganda

Patterns of risk exposure in first 1,000 days of life and health, behavior, and education-related problems at age 4.5: evidence from Growing Up in New Zealand, a longitudinal cohort study

A cluster of children with facial nerve palsy in a high prevalence area for COVID-19